Isoniazid Induced Generalized Lichenoid Drug Eruption: An Unusual Offender
Author(s) -
Pratima Singh,
Deepak Nathiya,
Sonal Jain,
P. Albert Arockia Raj,
Supriya Suman,
Balvir S. Tomar
Publication year - 2020
Publication title -
indian journal of pharmacy practice
Language(s) - English
Resource type - Journals
ISSN - 0974-8326
DOI - 10.5530/ijopp.13.3.44
Subject(s) - medicine , drug eruption , isoniazid , dermatology , drug , pharmacology , tuberculosis , pathology
Isoniazid also known as isonicotinic acid hydrazide is first line drug in anti-tubercular regimen. We report the case of lichenoid drug eruption due to this drug. Case-Report: A Sixty four-year old man received treatment for transverse myelitis with pulmonary TB. After almost four months of initiation of regimen he developed viloaceous lesions first from back and gradually involving B/L extremities. A skin punch biopsy is indicative of drug-induced lichenoid drug eruption. Isoniazid dechallenge and rechallenge confirmed the diagnosis of “Isoniazid induced lichenoid Drug eruption”. Discussion: Incidence of isoniazid induced CADR is 0.98%. Diagnosis decisionmaking should be on the basis of critical analysis of case. Role of Pharmacovigilance is crucial to understand quality and frequency of adverse drug reactions
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom